Kim et al., “The Long Isoform of Rat Throtropin-releasing Hormone Receptor Down-regulates Gq, Journal Biology Chemistry” Chem. Abstr., vol. 269(31), pp. 19933-19940 (1994). |
“P8/21 Thyrotropin Releasing Hormone (TRH) in Ultra Low Doses Decreases Severity of Seizures in Rats” N.E. Chepournova et al., Neuropeptides 26 (Supp. 1):52 (1994). |
“Seizure suppression in kindling epilepsy by intracerebral implants of GABA-but not by noradrenaline-releasing polymer matrices”, Merab Kokaia et al, E P Brain Res (1994), 100:385-394. |
“Interstitial Chemotherapy of the 9L Gliosarcoma: Controlled Release Polymers for Drug Delivery in the Brain”, Rafael J. Tamargo et al., Cancer Res. 53:329-33 (1993). |
“Anticonvulsant Effect of DN-1417, a Derivative of Thyrotropin-Releasing Hormone, and Liposome-Entrapped DN-1417, on Amygdaloid-Kindled Rats”, Norio Mori et al., Epilepsia, 33(6):994 1000 (1992). |
“Controlled release of polypeptides from polyanhydrides”, Eyal Ron et al., Proc. Nat'l. Acad. Sci. USA vol. 90, pp. 4176-4180 (May 1993). |
“Drug Delivery to the Brain Using Polymers”, Abraham Domb et al., Critical Reviews in Therapeutic Drug Carrier Systems, 8(1):1-17 (1991). |
“The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers”, Stuart A Grossman, M.D., et al., J. Neurosurg 76:640-647 (1992). |
“Gi Down-regulation as a Mechanism for Heterologous Desensitization in Adipocytes”, Allan Green et al., The Journal of Biological Chemistry, vol. 267, No. 5, pp. 3223-3229 (1992). |
“Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications” Graeme Milligan, TIPS, vol. 14, pp. 413-418, (Nov. 1993). |
“Thyrotropin-Releasing Hormone-Induced Subcellular Redistribution and Down-regulation of G11α: Analysis of Agonist Regulation of Coexpressed G11α Species Variants”, Molecular Pharmacology, 49:646-655 (1996). |